THE USE OF THE BOTULINUM TOXIN A FOR THE TREATMENT OF OCULOMOTOR PATHOLOGY

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


The use of the botulinum toxin A can be the method of choice for the treatment of oculomotor pathology. In certain cases of strabismus, this technique provides the sole correct and justified tool for the management of this condition. There are numerous publication concerning this issue in the foreign literature, but they do not permit to develop the well defined criteria for the application of the botulinum toxin A in the ophthalmological practice Specifically, such issues as the timing and dosages of botulinum toxin A administration remain to be addressed and solved. Of special interest is the application of the botulinum toxin A for the treatment of nystagmus. The expediency of the application of the botulinum toxin A for the treatment of oculomotor pathology should be estimated on an individual basis.

Full Text

Restricted Access

About the authors

Aleksandr Vyacheslavovich Apaev

The Helmholtz Moscow Research Institute of Eye Diseases, Russian Ministry of Health

Email: doc229@mail.ru
Moscow, 105062, Russian Federation
research scientist, Department of Pathology of Refraction, Binocular Vision and Ophthalmoergonomics, The Helmholtz Moscow Research Institute of Eye Diseases, Russian Ministry of Health, Moscow, 105062, Russian Federation

G. L Gubkina

The Helmholtz Moscow Research Institute of Eye Diseases, Russian Ministry of Health

Moscow, 105062, Russian Federation

E. P Tarutta

The Helmholtz Moscow Research Institute of Eye Diseases, Russian Ministry of Health

Moscow, 105062, Russian Federation

References

  1. Scott A.B. Pharmacologic weakening of extraocular muscles A.B. Scott, A. Rosenbaum, C. Collins Invest. Ophthal. 1973; 12: 924-7.
  2. Scott A.B. Botulinum toxin injection of eye muscles to correct strabismus. Trans. Am. Ophalmol. Soc. 1981; 79: 734-70.
  3. Scott A.B. Botulinum A toxin injection as a treatment for blepharospasm. A.B. Scott, R.A. Kennedy, H.A. Stubbs. Arch. Ophthalmol. 1985; 103: 347-50.
  4. Elston J.S., Lee J.P. Paralytic strabismus: the role of botulinum toxin. Br. J. Ophthalmol. 1985; 69(12): 891-6.
  5. Schantz E.J., Johnson E.A. Botulinum toxin: The Story of Its Development For the Treatment of Human Disease. Perspectives in Biology and Medicine. 1997; 40: 317-27.
  6. Simpson L.L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol. Rev. 1981 Sep; 33(3): 155-88.
  7. Schiavo G., Boquet P., DasGupta B.R., Montecucco C. Membrane interactions of tetanus and botulinum neurotoxins: a photolabelling study with photoactivatable phospholipids. J. Physiol. (Paris). 1990; 84: 180-7.
  8. Montecucco C., Schiavo G. Mechanisms of action of tetanus and botulinum neurotoxins. Mol. Microbio. 1994; 13: 1-8.
  9. Артеменко А.Р. А.Л. Куренков и др. Механизм действия ботулинического токсина типа А. Пластическая хирургия и косметология. 2010; 1: 174-7.
  10. Arnon S.S., Schechter R., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Hauer J., Layton M., Lillibridge S., Osterholm M.T., O’Toole T., Parker G., Perl T.M., Russell P.K., Swerdlow D.L., Tonat K. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001; 285: 1059-70.
  11. Scott A.B. Change of eye muscle sarcomeres according to eye position. J. Pediatr. Ophthalmol. Strabismus. 1994; 31: 85-8.
  12. Stahl J.S., Averbuch-Heller L., Remler B.F., Leigh R.J. Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin. Neurology. 1998; 51: 1093-9.
  13. Benabent E.C., Garcia Hermosa P., Arrazola M.T., et al. Botulinum toxin injection without electromyographic assistance. J. Pediatr. Ophthalmol. Strabismus. 2002; 39: 231-4.
  14. Compos E.C., Schiavi C., Bellusci C. Critical age of botulinum toxin treatment in essential infantile esotropia. J. Pediatr. Ophthalmol. Strabismus. 2000; 37: 328-32.
  15. Kao L.Y. Subtenon injection of botulinum toxin for treatment of traumatic sixth nerve palsy. L.Y. Kao, A.N. Chao. J. Pediatr. Ophthalmol. Strabismus. 2003; 40: 27-30.
  16. Xiao-Mei Wan, Rui-Xue Chu, Hua-Qing Gong. Minimally invasive botulinum toxin type A injection from the ocular surface to extraocular muscles. Int. J. Ophthalmol. 2011; 4(2): 179-81.
  17. Helveston E.M., Pogrebniak A.E. Treatment of acquired nystagmus with botulinum A toxin. Am. J. Ophthalmol. 1988; 106(5): 584-6.
  18. Gomez de Liano P. Paralisis oculomotora infantile. P. Gomez de Liano. Actualizacion en cirugia oftalmica pediatrica. 2000. Parte 6. Capitulo 46.
  19. Scott A.B., Magoon E.H., McNeer K.W., Stager D.R. Botulinum treatment of childhood strabismus. Ophthalmology. 1990; 97: 1434-8.
  20. Siatkowski R.M. Third, fourth, and sixth nerve palsies. Focal Points. 1996; XIV: 1-14.
  21. Holmes J.M., Leske D.A., Christiansen S.P. Initial treatment outcomes in chronic sixth nerve palsy. J. AAPOS. 2001; 5: 370-6.
  22. Плисов И.Л., Атаманов В.В., Пузыревский К.Г. Опыт применения инъекций препарата диспорт в экстраокулярные мышцы при лечении паралитического косоглазия. Вестник ОГУ. 2004; S: 157-60.
  23. Crouch E.R. Use of botulinum toxin in strabismus. Curr. Opin. Ophthalmol. 2006; 17: 435-44.
  24. Metz H.S. Botulinum toxin treatment of acute sixth and third nerve palsy. H.S. Metz, M. Mazow. Graefes Arch. Clin. Exp. Ophthalmol. 1988; 226: 141.
  25. Tejefor J., Rodríguez J.M. Retreatment of children after surgery for acquired esotropia: reoperation versus botulinum injection. Br. J. Ophthalmol. 1998; 82: 110-4.
  26. Khan S. Two horizontal rectus eye muscle surgery combined with botulinum toxin for the treatment of very large angle esotropia A pilot study. Binocul. Vis.Strabismus Q. 2005; 20: 15-20.
  27. de Alba Campomanes A.G., Binenbaum G., Campomanes Eguiarte G. Comparison of botulinum toxin with surgery as primary treatment for infantile esotropia. J. AAPOS 2010; 1: 111-6.
  28. Dawson E.L., Lee J.P. Does Botulinum toxin have a role in the treatment of smallangle esotropia? Strabismus. 2004; 12: 257-60.
  29. McNeer K.W., Tucker M.G., Spencer R.F. Botulinum toxin management of essential infantile esotropia in children. Arch. Ophthalmol. 1997; 115: 1411-8.
  30. Dawson E.L., Marshman W.E., Lee J.P. Role of botulinum toxin A in surgically overcorrected exotropia. J. AAPOS. 1999; 3: 269-71.
  31. Lawson J.M., Kousoulides L., Lee J.P. Long-term results of botulinum toxin in consecutive and secondary exotropia: outcome in patients initially treated with botulinum toxin. J. AAPOS. 1998; 2: 195-200.
  32. Lennerstrand G., Nordbo O.A., Tian S., et al. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta. Ophthalmol. Scand. 1998; 76: 27-37.
  33. Carruthers J. The treatment of congenital nystagmus with Botulinum. J. Pediatr. Ophthalmol. Strabismus. 1995; 32: 306-8.
  34. Tomsak R.L., Remler B.F., Averbuch-Heller L., et al. Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin. Am. J. Ophthalmol. 1995; 119: 489-96.
  35. Hoyt C.S., Taylor D. Strabismus treatment. Pediatr. Ophthalmol. Strabismus. 2013; 853-60.

Statistics

Views

Abstract - 82

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2017 Eco-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies